Sprott Resource Corp

(SCPZF)

By |

Profile

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers.

Contact Information

Website: www.aileronrx.com
Email: ddougherty@aileronrx.com
Main Phone: +1 617 995-0900
Address: 490 Arsenal Way
Address 2: Suite 210
State: MA
City / Town: Watertown
Country: US
Postal Code: 02472

Issuer Information

Exchange: OTO
CEO: Manuel C. Alves Aivado
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers.

Contact Information

Website: www.aileronrx.com
Email: ddougherty@aileronrx.com
Main Phone: +1 617 995-0900
Address: 490 Arsenal Way
Address 2: Suite 210
State: MA
City / Town: Watertown
Country: US
Postal Code: 02472

Issuer Information

Exchange: OTO
CEO: Manuel C. Alves Aivado
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.45 $ 0. (0.00%)
Last Price 0.45 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.45
Last Trade Volume 0 52 Wk Hi 0.50 52 Wk Low 0.29
Market Cap 18.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,684,649.00 EPS (TTM) -0.76 PE Ratio -1.40 Exchange OTCPK